Table 2. Individual tumor volume outcome of the 12 patients treated primarily with cabergoline (CBG) (*last available measurement while on CBG).
| Patient | Age | Sex | Cavernous Sinus invasion | Tumor volume mm3 | Status | |
|---|---|---|---|---|---|---|
| Pre-CBG | On CBG* | |||||
| 1 | 50 | M | No | 10195 | 13659 | Growth |
| 2 | 71 | M | No | 2028 | 2028 | Stable |
| 3 | 46 | F | No | 678 | 778 | Stable |
| 4 | 76 | F | No | 1949 | 1714 | Stable |
| 5 | 80 | F | Yes | 16933 | 16900 | Stable |
| 6 | 44 | F | No | 1291 | 2198 | Growth |
| 7 | 54 | M | Yes | 9538 | 523 | Reduction |
| 8 | 64 | M | No | 653 | 100 | Reduction |
| 9 | 73 | M | Yes | 5610 | 6939 | Growth |
| 10 | 66 | F | Yes | 2395 | 2763 | Stable |
| 11 | 41 | M | Yes | 10257 | 8164 | Reduction |
| 12 | 75 | F | Yes | 691 | 523 | Reduction |